Skip to main content
. 2022 Feb 11;2(2):90–98. doi: 10.1158/2767-9764.CRC-21-0142

FIGURE 3.

FIGURE 3

Presence of mSEPT9 was significantly associated with EOCRC survival status. Comparison of presence of mSEPT9, normalized by batch and ACTB, by stage (A; P = 0.06, Ptrend = 0.13), tumor grade (B; P = 0.98, Ptrend = 0.88), tumor site (C; P = 0.65), and survival status (D; P = 0.02).